BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24033365)

  • 21. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
    Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
    J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Akamata K; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2012 Jul; 304(5):401-6. PubMed ID: 22526325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Ohmatsu H; Sugaya M; Miyagaki T; Suga H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Br J Dermatol; 2012 Aug; 167(2):359-67. PubMed ID: 22512719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis.
    Goeldel AL; Cornillet-Lefebvre P; Durlach A; Birembaut P; Bernard P; Nguyen P; Grange F
    Br J Dermatol; 2010 Apr; 162(4):822-9. PubMed ID: 19906072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
    Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
    J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
    Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
    J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis.
    Stutz N; Johnson RD; Wood GS
    J Am Acad Dermatol; 2012 Dec; 67(6):1327.e1-10. PubMed ID: 22884443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
    McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
    J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
    García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL).
    Fava P; Bergallo M; Astrua C; Brizio M; Galliano I; Montanari P; Daprà V; Novelli M; Savoia P; Quaglino P; Fierro MT
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e27-e29. PubMed ID: 26935979
    [No Abstract]   [Full Text] [Related]  

  • 38. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.
    Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J
    J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of polymorphic variants in endothelin-1 (EDN1) genes with the therapy of patients with cutaneous T-cell lymphomas].
    Vasků V; Bienertová-Vasků J; Pávková-Goldbergová M; Semrádová V; Vasků A
    Cas Lek Cesk; 2006; 145(2):144-7. PubMed ID: 16521405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.